Genome Editing Technologies: Defining a Path to Clinic
Jacqueline Corrigan‐Curay(National Institutes of Health), Matthew H. Porteus(Lucile Packard Children's Hospital), Eugene Rosenthal(National Institutes of Health), Robert Jambou(National Institutes of Health), Paula M. Cannon(University of Southern California), Donald B. Kohn(University of California, Los Angeles), Gang Bao(Tianjin Stomatological Hospital), Michel Sadelain(Columbia University Irving Medical Center), Andrew M. Scharenberg(CTI BioPharma (Italy)), Morad Hassani(National Institutes of Health), Dana Carroll(University of Utah), Christof von Kalle(Luxembourg Institute of Health), Toni Cathomen(University of Freiburg), Feng Zhang(Broad Institute), Aparna Singh(National Institutes of Health), Marina O’Reilly(National Institutes of Health), J. Keith Joung(Massachusetts General Hospital), David B. Roth(University of Miami), Frederic D. Bushman(University of Pennsylvania)
Cited by 99
Related Papers
QIIME allows analysis of high-throughput community sequencing data
|Nature Methods|2010|36k
Multiplex Genome Engineering Using CRISPR/Cas Systems
|Science|2013|15.9k
Genome engineering using the CRISPR-Cas9 system
|Nature Protocols|2013|11.8k
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k